EU releases regular vaccine safety updates
(VOVWORLD) - The European Medicines Agency released its regular vaccine safety updates on Wednesday, which added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a possible side-effect of AstraZeneca's COVID-19 vaccine.
 (Photo: PAP/VNA) |
The watchdog said a relationship between GBS and the AstraZeneca shot is at least a reasonable possibility after 833 cases of GBS were reported out of 592 million doses of the vaccine given worldwide by July 31. The EMA categorized the side-effect as "very rare", the lowest frequency of side-effect category it has, and emphasized that the benefits of the shot outweigh the risks.
The EMA also tagged some other less severe side-effects to vaccines from Johnson & Johnson and Moderna.